Fuad El-Hibri
American businessman
Fuad El-Hibri (March 2, 1958 – April 23, 2022) was a prominent American businessman known for his role as the founder and executive chairman of Emergent BioSolutions, a multinational biopharmaceutical company. His leadership in the biotechnology industry, particularly in the development and production of vaccines and therapeutics, has been widely recognized.
Early Life and Education
Fuad El-Hibri was born in Hildesheim, Germany, to a Lebanese father and a German mother. He spent his early years in Germany before moving to the United States for higher education. El-Hibri attended Stanford University, where he earned a Bachelor of Arts in Economics. He later pursued a Master of Business Administration from Yale School of Management.
Career
Early Career
Before founding Emergent BioSolutions, El-Hibri held various positions in the telecommunications and investment sectors. He worked for Citibank in Saudi Arabia and later joined Booz Allen Hamilton as a management consultant. His early career provided him with a strong foundation in business strategy and operations.
Emergent BioSolutions
In 1998, Fuad El-Hibri founded Emergent BioSolutions, initially focusing on the development of vaccines and therapeutics for infectious diseases. Under his leadership, the company became a key supplier of the anthrax vaccine to the United States Department of Defense.
El-Hibri's vision for Emergent BioSolutions was to address public health threats by developing innovative solutions. The company expanded its portfolio to include treatments for smallpox, botulism, and other biological threats. El-Hibri's strategic acquisitions and partnerships helped position Emergent as a leader in the biodefense industry.
Philanthropy and Legacy
Fuad El-Hibri was also known for his philanthropic efforts. He established the El-Hibri Foundation, which focuses on promoting peace and understanding through interfaith dialogue and education. The foundation supports various initiatives aimed at fostering social justice and community development.
El-Hibri's contributions to the biotechnology field and his philanthropic endeavors have left a lasting impact. His leadership style and commitment to public health continue to inspire future generations of entrepreneurs and business leaders.
Personal Life
Fuad El-Hibri was married and had three children. He was known for his passion for education and his commitment to fostering innovation in the biotechnology sector. El-Hibri passed away on April 23, 2022, leaving behind a legacy of leadership and service.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
